280 likes | 771 Views
Case Presentation. 33 year old woman presented to local health center with fever, rash, and orthostatic hypotensionSeen 2 weeks prior in the ER for menorrhagia and orthostasis, received hydration5 days prior to admission, developed fever to 105F at home and mild headache; took antihistamine12 hours later developed rash which lasted until going to her doctor's office .
E N D
1. Difficult Case of Fever & Rash Andrew Dionne, MD
Dan Onion, MD
Roy Miller, MD
3. PMH: Type 2 Diabetes, Mild hypertension, Bipolar Affective Disorder
Meds: Glucophage, Tegretol, recently discontinued a beta-blocker
Allergy: Penicillin
Lives in area with her teenage son, works as a secretary, smokes 1 ppd, no alcohol
Family history notable for CAD, BPAD Case Presentation
4. Initial exam
Alert, oriented
Pulse 120 (sitting & standing), BP 140/90 supine & fell to 95 systolic with standing
HEENT, Cardiac, Lung Exams normal
Abdomen with mild RLQ tenderness
Extremities no edema
Skin maculopapular rash confluent on upper arms, chest, back, knees
Neuro normal Case Presentation
5. Initial Laboratory Data
WBC 4,000 with 48 polys, 30 bands, 17 lymphs
Hgb 11.3, HCT 33.7; plt 215,000
Electrolytes, BUN/Cr WNL; glucose 120
Protein 6.7 (Alb 3.0), AST 112, ALT 93, Alk Phos 181, Bili 0.6
Blood, Urine & Vaginal Cultures were ordered
Imaging
Chest X-Ray was normal
Pelvic U/S was normal
Head CT was normal Case Presentation
6. Was admitted with a diagnosis of toxic shock syndrome vs. viral illness (mono, hepatitis)
Started on IV cefazolin and clindamycin
Blood, urine, & vaginal cultures had no growth
One dose of IVG was given
Patient had no clinical improvement with continued fevers, postural hypotension; rash worsened and edema, then anasarca, came on
Left axillary lymphadenopathy developed Case Presentation
7. Further Lab Work revealed
WBC fell to 3600 then increased to 13,000
H/H increased to WNL
Plt count increased to >500K
PT 15.6, INR 1.4, PTT 31
TSH 7.40, FT4 normal
Alk Phos, AST, ALT remained 2x normal; GGTP 618
CPK 3, ESR 10, Tegretol 6.6, RPR NR, Monospot (-)
Repeat Blood Cx were negative Case Presentation
8. On hospital day #7, Tegretol and Glucophage were discontinued
Gallium scan done to r/o abscess was negative
Because of elevated LFTs, RUQ U/S was done and came back negative; CT Abd/Pelvis (-)
Because of prolonged sinus tach and orthostasis, an echocardiogram was performed and showed small pericardial effusion but normal LV size and function Case Presentation
9. Diagnosis of small vessel vasculitis considered
Repeat ESR 5
Immune Survey WNL except IgG, IgA slightly low, C3 high
ANA, RF (-); P-ANCA, C-ANCA, Antimit AB sent out (and came back negative)
Biopsy of rash done from 2 sites
Intraepidermal pustular dermatitis
Dermatology and rheumatology consults placed Case Presentation
10. Further study brought about consideration of anticonvulsant hypersensitivity syndrome
Patient started on IV then PO steroids on hospital day #11
Steady clinical improvement of edema, pruritus, rash, and hypotension Case Presentation
11. Anticonvulsant Hypersensitivity Syndrome AKA Dilantin Hypersensitivity Syndrome, Pseudolymphoma syndrome
Reported primarily with phenytoin, carbamazepine, and phenobarbital
Between 1/1000 and 1/10,000 exposures
First described by Chaiken et al in 1950
Increased risk with race and family history
Onset of symptoms delayed with 1st exposure- 2 weeks to 3 months
12. Phenytoin
Carbamazepine
Phenobarbital
Primidone
Lamotrigine
Valproic Acid
Ethosuximide Dapsone
Sulfasalazine
Sulfonamides
Allopurinol
Diltiazem
Mexiletine
Minocycline
Terbinafine Anticonvulsant Hypersensitivity SyndromeCausative Medications
13. Fever 90-100%
Rash 90%
Lymphadenopathy 70%
Periorbital/Facial Edema 25%
Hepatitis 50-60%
Hematologic abnormal. 50%
Multi-organ involvement 60%
Myalgia, arthralgia 20%
Pharyngitis 10% Anticonvulsant Hypersensitivity SyndromeClinical Findings
14. Viral diseases
Hepatitis
Influenza
CMV, EBV
HIV
Collagen Vascular Dis.
Kawasaki Syndrome
Lymphoma
Syphilis
Porphyria Anticonvulsant Hypersensitivity SyndromeDifferential Diagnosis Hypereosinophilic syndrome
Toxic Shock Syndrome
Other drug reactions
Erythema multiforme
Toxic Epidermal Necrolysis
Serum sickness
15. Anticonvulsant Hypersensitivity SyndromeDermatologic Findings Begins as patchy, macular erythema
Dusky, confluent, pruritic papular rash
Edema, esp. on face
Differentiates from other drug rashes
Sterile follicular pustules
May progress to erythema multiforme or toxic epidermal necrolysis
16. Anticonvulsant Hypersensitivity SyndromeOther Findings Lymphadenopathy
Localized or generalized
Lymphoid hyperplasia
May be atypical cells similar to lymphoma
Small number have coexistant or subsequently develop lymphoma- “pseudo-pseudolymphoma syndrome”
Hepatitis
Most common cause of death; Mortality 18-40%
LFTs may continue rise after off med, take up to 1 year to resolve
17. Anticonvulsant Hypersensitivity SyndromeOther Findings Hematologic
Leukocytosis with atypical lymphs
Eosinophilia
Coombs (-) hemolytic anemia
Immunologic
Ig, ESR, Complement usually normal
Other
Nephritis, pancreatitis, pneumonitis
Polyarteritis nodosa, myopathy, myocarditis
Hypo- and hyperthyroidism
18. No relation to drug dosage or levels
One theory proposed like graft-versus-host disease, i.e. lymphocytes have altered recognition of “self”
Others say due to circulating autoantibodies
Shear and Spielberg, 1988 suggested due to a toxic metabolite
? Related to HHV-6 infection Anticonvulsant Hypersensitivity SyndromePathophysiology
19. Anticonvulsants metabolized by cytochrome p450 to arene oxide metabolite
Metabolite detoxified by epoxide hydrolase
Enzyme may be lacking or mutated in some people
Toxin may cause direct cell death or trigger autoimmune response
In vitro enzyme testing can be performed but not readily available Anticonvulsant Hypersensitivity SyndromePathophysiology
20. Primary therapy is discontinuation of offending medication prior to significant organ involvement
Supportive care with O2, IVF, etc
Treat rash with topical steroids, wet wraps, antihistamines
IV steroids widely used and felt to be helpful but not clinically proven
0.5-2 mg/kg daily Anticonvulsant Hypersensitivity SyndromeTreatment
21. May take weeks to months for symptoms and lab abnormalities to improve
Patient should be warned never to use anticonvulsants
Even small doses can lead to immediate, life-threatening reactions
Consider warning bracelet if prone to status epilepticus
? Follow closely for lymphoma
Warn family members about risk Anticonvulsant Hypersensitivity SyndromeFollow-Up